Full Text View
Tabular View
No Study Results Posted
Related Studies
Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
This study has been completed.
Study NCT00214968   Information provided by Cephalon
First Received: September 14, 2005   Last Updated: April 20, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Excessive Daytime Sleepiness
Narcolepsy
Additional conditions recognized in this trial
Sleep Apnea, Obstructive
More general conditions related to this trial
Apnea
Disorders of Excessive Somnolence
Dyssomnias
Mental Disorders
Nervous System Diseases
Respiration Disorders
Respiratory Tract Diseases
Sleep Apnea Syndromes
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
PROVIGIL (modafinil)
Additional drug interventions recognized in this trial
Modafinil
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Cephalon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services